BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7994048)

  • 1. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
    Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
    Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
    Fritzer-Szekeres M; Grusch M; Luxbacher C; Horvath S; Krupitza G; Elford HL; Szekeres T
    Exp Hematol; 2000 Aug; 28(8):924-30. PubMed ID: 10989193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF: modulation of biochemical and cytotoxic effects of tiazofurin in HL-60 cells.
    Fritzer M; Gharehbaghi K; Pillwein K; Chiba P; Goldenberg H; Szekeres T
    Br J Haematol; 1993 Jul; 84(3):552-4. PubMed ID: 8105873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways].
    Szekeres T; Fritzer M; Schön HJ; Findenig G; Lhotka C
    Wien Klin Wochenschr; 1994; 106(14):459-63. PubMed ID: 7941593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.
    Szekeres T; Vielnascher E; Novotny L; Vachalkova A; Fritzer M; Findenig G; Göbl R; Elford HL; Goldenberg H
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):785-9. PubMed ID: 8620054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells.
    Rosenberger G; Fuhrmann G; Grusch M; Fassl S; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
    Life Sci; 2000 Nov; 67(26):3131-42. PubMed ID: 11191620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of tiazofurin and retinoic acid on differentiation and colony formation of HL-60 leukemia cells.
    Yamaji Y; Natsumeda Y; Yamada Y; Irino S; Weber G
    Life Sci; 1990; 46(6):435-42. PubMed ID: 1968220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.
    Szekeres T; Gharehbaghi K; Fritzer M; Woody M; Srivastava A; van't Riet B; Jayaram HN; Elford HL
    Cancer Chemother Pharmacol; 1994; 34(1):63-6. PubMed ID: 8174204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
    Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
    Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
    Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
    Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
    Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
    Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
    Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
    Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of memory to the terminal differentiation inducing activity of tiazofurin in HL-60 leukemia cells.
    Sokoloski JA; Sartorelli AC
    Leuk Res; 1991; 15(5):395-402. PubMed ID: 2046392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurin.
    Sokoloski JA; Blair OC; Carbone R; Sartorelli AC
    Exp Cell Res; 1989 May; 182(1):234-41. PubMed ID: 2714402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.